@parexel.com
Parexel is a clinical research organization that is dedicated to finding better ways to improve healthcare around the world.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
SVG
Logo
SVG
Icon
PNG
About
Description
Parexel is a leading global biopharmaceutical services company headquartered in Waltham, Massachusetts, United States. The company was founded in 1982 by Josef von Rickenbach and organic chemist Anne Sayigh. It began as a small consulting firm specializing in helping pharmaceutical companies navigate the complex process of drug development and gained recognition for its expertise in clinical trials.
Parexel's headquarters in Waltham, Massachusetts is a state-of-the-art facility that houses various departments such as research and development, clinical operations, data management, and regulatory affairs. The headquarters serve as the nerve center of the company's operations, overseeing its global activities. The company offers a wide range of products and services to support the entire drug development lifecycle.
These include clinical trial management, regulatory consulting, data analytics, pharmacovigilance, market access, and technology solutions. Parexel has built a reputation for its expertise in managing complex clinical trials and has a global network of clinical research sites. Parexel operates on a global scale with a presence in over 50 countries.
The company has established numerous subsidiaries and strategic partnerships to enhance its services. Notably, Parexel has formed joint ventures with companies like PAREXEL International (China) Co., Ltd. In terms of market position, Parexel is considered one of the top players in the biopharmaceutical services industry.
The company has a strong competitive position, with a diverse portfolio of clients ranging from emerging biotech to large pharmaceutical companies. Parexel's global sales have consistently grown over the years, and it has successfully carved a niche for itself in the clinical research market. Over the years, Parexel has experienced several significant events and achieved notable milestones.
In 1990, the company became publicly traded on the NASDAQ stock exchange. It has since expanded through strategic acquisitions, including the acquisition of ClinPhone in 2006 and Liquent in 2010. As of the latest updates, Parexel has continued to expand its service offerings and global reach.
The company is actively involved in supporting COVID-19 vaccine development and has collaborated with leading pharmaceutical companies in conducting clinical trials for potential vaccines. Parexel also remains committed to leveraging technology and data analytics to enhance its clinical trial processes and improve patient outcomes. In conclusion, Parexel is a globally recognized biopharmaceutical services company headquartered in the United States.
With a strong market position and a wide range of services, the company continues to play a pivotal role in advancing drug development globally. (359 words)
Company Type
Privately Held
Company Size
10,001+
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories